Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 1 52-1, 2005, Pages

  Park, So Young ^a   Kim, Hyo Jeong ^a   Wang, Shupei ^b   Higashimori, Takamasa ^a   Dong, Jianjing ^a   Kim, Yoon Jung ^a   Cline, Gary ^a   Li, Hong ^b   Prentki, Marc ^c   Shulman, Gerald I ^a   Mitchell, Grant A ^b   Kim, Jason K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Glucose metabolism; High fat feeding; Insulin action; Lipid metabolism; Triglyceride

Indexed keywords

ACYL COENZYME A; FATTY ACID; HORMONE SENSITIVE LIPASE; INSULIN; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FAT INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART FAILURE; HYDROLYSIS; HYPERINSULINEMIA; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID DIET; LIPID METABOLISM; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE SPECIFICITY;

EID: 20544449419     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00251.2004     Document Type: Article

References (60)

1. Anthonsen MW, Ronnstrand L, and Wernstedt C. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem 273: 213-221, 1998.
2. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
3. Boden G. Obesity, free fatty acids, and insulin resistance. Curr Opin Endo Diabetes 8: 235-239, 2001.
4. Boden G and Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 32: 14-23, 2002.
5. Boden G, Lebed B, Schatz M, Homko C, and Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50: 1612-1617, 2001.
6. Chalkley SM, Hettiarachchi M, Chisholm DJ, and Kraegen EW. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 47: 1121-1126, 1998.
7. Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E, Gavrilova O, and Reitman ML. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106: 1221-1228, 2000.
8. Chatham JC, Forder JR, and McNeill JH. The Heart in Diabetes. Norwell, MA: Kluwer Academic, 1996.
9. Coppack SW, Evans RD, Fisher RM, Frayn KN, Gibbons GF, Humphreys SM, Kirk MJ, Potts JL, and Hockaday TDR. Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41: 264-272, 1992.
10. DeFronzo RA. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667-687, 1988.
11. Eriksson H, Ridderstrale M, Degerman E, Ekholm D, Smith CJ, Manganiello VC, Belfrage P, and Tornqvist H. Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin. Biochim Biophys Acta 1266: 101-107, 1995.
12. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, and Kelly DP. The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. J Clin Invest 109: 121-130, 2002.
13. Finck BN, Han X, Courtois M, Almond F, Nerbonne JM, Kovacs A, Gross RW, and Kelly DP. A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation of dietary fat content. Proc Natl Acad Sci USA 100: 1226-1231, 2003.
14. Fortier M, Wang SP, Mauriege P, Meriem S, Mfuma L, Li H, Levy E, Richard D, and Mitchell GA. Hormone-sensitive lipase-independent adipocyte lipolysis during β-adrenergic stimulation, fasting, and dietary fat loading. Am J Physiol Endocrinol Metab 287: E282-E288, 2004.
15. Frayn KN, Coppack SW, Fielding BA, and Humphreys SM. Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization. Adv Enzyme Regul 35: 163-178, 1995.
16. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37: 693-707, 1996.
17. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, and Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade. Diabetes 48: 1270-1274, 1999.
18. Haemmerle G, Zimmermann R, Strauss JG, Kratky D, Riederer M, Knipping G, and Zechner R. Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle. J Biol Chem 277: 12946-12952, 2002.
19. Hajri T, Han XX, Bonen A, and Abumrad NA. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest 109: 1381-1389, 2002.
20. Harada K, Shen WJ, Patel S, Natu V, Wang J, Osuga JI, Ishibashi S, and Kraemer FB. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice. Am J Physiol Endocrinol Metab 285: E1182-E1195, 2003.
21. Holm C, Osterlund T, Laurell H, and Contreras JA. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr 20: 365-393, 2000.
22. Holm C, Kirchgessner TG, Svenson KL, Fredrikson G, Nilsson S, Miller CG, Shively JE, Heinzmann C, Sparkes RS, Mohandas T, Lusis AJ, Belfrage P, and Schotz MC. Hormone-sensitive lipase: sequence, expression, and chromosomal localization to 19 cent-q13.3. Science 241: 1503-1506, 1988.
23. Hotamisligil GS, Shargill NS, and Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
24. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066-1084, 1994.
25. Kahn CR, Chen L, and Cohen SE. Unraveling the mechanism of action of thiazolidinediones. J Clin Invest 106: 1305-1307, 2000.
26. Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB, and Kim JK. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53: 1060-1067, 2004.
27. Kim JK, Gavrilova O, Chen Y, Reitman ML, and Shulman GI. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 275: 8456-8460, 2000.
28. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, Breslow JL, and Shulman GI. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 98: 7522-7527, 2001.
29. Kim JK, Fillmore JJ, Gavrilova O, Chao L, Higashimori T, Choi H, Kim HJ, Yu C, Chen Y, Qu X, Haluzik M, Reitman ML, and Shulman GI. Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice. Diabetes 52: 1311-1318, 2003.
30. Klannemark M, Orho M, Langin D, Laurell H, Holm C, Reynisdottir S, Arner P, and Groop L. The putative role of the hormone-sensitive lipase gene in the pathogenesis of Type II diabetes mellitus and abdominal obesity. Diabetologia 41: 1516-1522, 1998.
31. 1H NMR spectroscopy study. Diabetologia 42: 113-116, 1999.
32. McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258: 766-770, 1992.
33. Mulder H, Sorhede-Winzell M, Congreras JA, Fex M, Strom K, Ploug T, Galbo H, Arner P, Lunderg C, Sundler F, Ahren B, and Holm C. Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. J Biol Chem 278: 36380-36388, 2003.
34. Nurjhan N, Consoli A, and Gerich J. Increased lipolysis and its consequence on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest 89: 169-175, 1992.
35. Osuga JI, Ishiashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A, Shionoiri Yahagi N F, Kraemer FB, Tsutsumi O, and Yamada N. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 97: 787-792, 2000.
36. Park SY, Finck BN, Kim HJ, Higashimori T, Kelly DP, and Kim JK. Heart-specific activation of PPARα causes insulin resistance in heart and liver. Circulation, Suppl IV 108: 61, 2003.
37. Pederson TM, Kramer DL, and Rondinone CM. Serine/threonine phosphorylation of IRS-1 triggers its degradation. Possible regulation by tyrosine phosphorylation. Diabetes 50: 24-31, 2001.
38. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic patients. Diabetes 48: 1600-1606, 1999.
39. Previs SF, Withers DJ, Ren JM, White MF, and Shulman GI. Contrasting effects of 1RS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem 275: 38990-38994, 2000.
40. Randle PJ, Garland PB, Hales CN, and Newsholme EA. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
41. Reaven GM. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
42. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, and Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859-2865, 1996.
43. Rodrigues B and McNeill JH. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 26: 913-922, 1992.
44. Roduit R, Masiello P, Wang SP, Li H, Mitchell GA, and Prentki M. A role for hormone-sensitive lipase in glucose-stimulated insulin secretion. A study in hormone-sensitive lipase-deficient mice. Diabetes 50: 1970-1975, 2001.
45. 307 via distinct pathways. J Clin Invest 107: 181-189, 2001.
46. Schwartz JP and Jungas RL. Studies on the hormone-sensitive lipase of adipose tissue. J Lipid Res 12: 553-562, 1971.
47. ob/ob mice. J Biol Chem 279: 15084-15090, 2004.
48. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000.
49. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, and Lazar MA. The hormone resistin links obesity to diabetes. Nature 409: 307-312, 2001.
50. Taegtmeyer H and Passmore JM. Defective energy metabolism of the heart in diabetes. Lancet 1: 139-141, 1985.
51. Talmud PJ, Palmen J, Nicaud V, and Tiret L. Association of the hormone sensitive lipase -60C > G variant with fasting insulin levels in healthy young men. Nutr Metab Cardiovasc Dis 12: 173-177, 2002.
52. Talmud PJ, Palmen J, Luan J, Flavell D, Byrne CD, Waterworth DM, and Wareham NJ. Variation in the promoter of the human hormone sensitive lipase gene shows gender specific effects on insulin and lipid levels: results from the Ely study. Biochim Biophys Acta 1537: 239-244, 2001.
53. Voshol PJ, Haemmerle G, Ouwens DM, Zimmermann R, Zechner R, Teusink B, Maassen JA, Havekes LM, and Romijn JA. Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice. Endocrinology 144: 3456-3462, 2003.
54. Wang SP, Laurin N, Himms-Hagen J, Rudnicki MA, Levy E, Robert MF, Pan L, Oligny L, and Mitchell GA. The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obesity Res 9: 119-128, 2001.
55. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Kara K, Mori Y, Ide T, Murakami K, and Tsuboyama-Kasaoka N. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946, 2001.
56. Yeaman SJ. Hormone-sensitive lipase-α multipurpose enzyme in lipid metabolism. Biochim Biophys Acta 1052: 128-132, 1990.
57. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, and Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002.
58. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, and Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKK-beta. Science 293: 1673-1677, 2001.
59. Zarich SW and Nesto RW. Diabetic cardiomyopathy. Am Heart J 118: 1000-1012, 1989.
60. Zimmerman R, Haemmerle G, Wagner EM, Strauss JG, Kratky D, and Zechner R. Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase-deficient white adipose tissue. J Lipid Res 44: 2089-2099, 2003.